ICD-10 Coding for Chronic Myeloid Leukemia(C92.10, C92.11, C92.12)
Complete ICD-10-CM coding and documentation guide for Chronic Myeloid Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Chronic Myeloid Leukemia
C92.1-C92.12Primary Range
Chronic myeloid leukemia codes
This range covers all phases of chronic myeloid leukemia, including chronic, accelerated, and blast phases.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C92.10 | Chronic myeloid leukemia, BCR/ABL-positive, in remission | Use when the patient is in remission with documented molecular response. |
|
| C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse | Use when the patient shows evidence of relapse with rising BCR/ABL1 levels. |
|
| C92.12 | Chronic myeloid leukemia, BCR/ABL-positive, in accelerated phase | Use when the patient is in the accelerated phase with documented clinical features. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for chronic myeloid leukemia
Essential facts and insights about Chronic Myeloid Leukemia
Primary ICD-10-CM Codes for chronic myeloid leukaemia
Decision Criteria
clinical Criteria
- Patient in major molecular response with sustained remission.
Applicable To
- Chronic myeloid leukemia in major molecular response
Excludes
- Chronic myeloid leukemia, BCR/ABL-positive, in relapse (C92.11)
Clinical Validation Requirements
- Major molecular response sustained for ≥12 months
- Last 2 qPCR results showing ≤0.01% IS
Code-Specific Risks
- Incorrectly coding remission without proper molecular documentation.
Coding Notes
- Ensure remission status is clearly documented with molecular evidence.
C92.11 - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
Use when the patient shows evidence of relapse with rising BCR/ABL1 levels.
Applicable To
- Chronic myeloid leukemia with loss of molecular response
Excludes
- Chronic myeloid leukemia, BCR/ABL-positive, in remission (C92.10)
Clinical Validation Requirements
- Two consecutive BCR/ABL1 IS results >0.1%
- Peripheral blood blasts >15%
Coding Notes
Document relapse status with molecular and clinical evidence.
C92.12 - Chronic myeloid leukemia, BCR/ABL-positive, in accelerated phase
Use when the patient is in the accelerated phase with documented clinical features.
Applicable To
- Chronic myeloid leukemia with accelerated phase features
Excludes
- Chronic myeloid leukemia, BCR/ABL-positive, in chronic phase (C92.10)
Clinical Validation Requirements
- 10-19% blasts in PB/BM
- Basophils ≥20%
- Platelets <100k unrelated to therapy
Coding Notes
Ensure phase-specific features are documented.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Chronic Myeloid Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C92.10.
Impact
Clinical: Leads to inappropriate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement.
Mitigation Strategy
Always specify the phase of CML., Document molecular response.
Impact
Reimbursement: Incorrect phase coding can lead to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Impacts the accuracy of clinical data.
Mitigation Strategy
Always document and code the specific phase of CML.
Impact
Failure to document the phase of CML can lead to audit issues.
Mitigation Strategy
Implement phase-specific documentation templates.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Chronic Myeloid Leukemia, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Chronic Myeloid Leukemia
Use these documentation templates to ensure complete and accurate documentation for Chronic Myeloid Leukemia. These templates include all required elements for proper coding and billing.
Chronic phase CML in remission
Specialty: OncologyRequired Elements
- Phase of CML
- BCR/ABL1 IS %
- TKI therapy details
- Response criteria
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Chronic Myeloid Leukemia? Ask your questions below.